| Product NDC: | 61748-017 |
| Proprietary Name: | IsonaRif |
| Non Proprietary Name: | Rifampin and Isoniazid |
| Active Ingredient(s): | 150; 300 mg/1; mg/1 & nbsp; Rifampin and Isoniazid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61748-017 |
| Labeler Name: | VersaPharm Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065221 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050901 |
| Package NDC: | 61748-017-60 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (61748-017-60) |
| NDC Code | 61748-017-60 |
| Proprietary Name | IsonaRif |
| Package Description | 60 CAPSULE in 1 BOTTLE (61748-017-60) |
| Product NDC | 61748-017 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Rifampin and Isoniazid |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20050901 |
| Marketing Category Name | ANDA |
| Labeler Name | VersaPharm Incorporated |
| Substance Name | ISONIAZID; RIFAMPIN |
| Strength Number | 150; 300 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient],Antimycobacterial [EPC] |